ArticleDiscover mental health2026
A pilot study on implementing a pharmacist-led holistic smoking cessation clinic in a psychiatric hospital.
Article in Discover mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmoking prevalence remains disproportionately high among individuals with psychiatric disorders. In Thailand, structured smoking cessation services are rarely embedded within routine psychiatric care. This pilot study describes the development and early evaluation of a pharmacist-led holistic smoking cessation clinic integrated into a tertiary psychiatric hospital in Northeastern Thailand.
methodsThis hospital-based service development project employed a two-phase design. Phase 1 involved stakeholder-informed co-design of the service model. Phase 2 consisted of pilot implementation among psychiatric outpatients with stable mental health status. During the recruitment period, 22 patients were screened and 18 were enrolled (intention-to-treat sample). The intervention combined pharmacologic support-including nicotine gum (2 mg), cytisine (1.5 mg titration over 25 days when clinically appropriate), and Cyanthillium cinereum (formerly Vernonia cinerea) herbal tea-with behavioral counseling and multidisciplinary follow-up over 12 weeks. Primary outcomes included feasibility and acceptability; secondary outcomes assessed preliminary smoking-related and psychological indicators.
resultsOf the 18 enrolled participants, 15 completed the 12-week program. Recruitment (81.8%), retention (83.3%), and session adherence (88.9%) exceeded predefined feasibility thresholds. At Week 12, 7-day point prevalence abstinence was 44.4% (8/18, intention-to-treat), and daily cigarette consumption significantly decreased. Patient satisfaction scores were high (mean 4.47/5). No serious adverse events or psychiatric relapses were observed.
conclusionThis pilot service demonstrates that a pharmacist-led holistic smoking cessation model can be feasibly integrated into psychiatric care in a provincial Thai hospital. Further controlled studies are warranted to evaluate long-term effectiveness and scalability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.